Finance

Lists
Why is CNC up 2.75%?
Dive Deeper
CNC:NYSE
Centene Corp
$68.86
+2.75%
(+1.84) 1D
$68.85
-0.01% (-0.010)
After hours
Closed: Oct 13, 4:03:32 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNC...
Open
$68.02
High
$69.70
Low
$66.38
Mkt. cap
34.02B
Avg. vol.
4.67M
Volume
5.26M
52-wk high
$69.70
52-wk low
$31.63
EPS
-$10.44
Beta
1.13
Shares outstanding
494.00M
No. of employees
61K
Open
$68.02
High
$69.70
Low
$66.38
Mkt. cap
34.02B
Avg. vol.
4.67M
Volume
5.26M
52-wk high
$69.70
52-wk low
$31.63
EPS
-$10.44
Beta
1.13
Shares outstanding
494.00M
No. of employees
61K
News stories
From web sources and news partners
Profile
Centene Corporation is an American for-profit healthcare company that serves as an intermediary for government-sponsored and privately insured healthcare programs. Based in Clayton, Missouri, Centene ranked No. 23 on the 2025 Fortune 500. Wikipedia
About Centene Corp
CEOSarah M. London
Employees61.1K
Founded1984
HeadquartersSt. Louis, Missouri, United States
SectorHealth care provider
Websitecentene.com
Analyst ratings
Based on 14 analysts giving stock ratings to CNC in the past 3 months
Buy
Buy
6
Hold
8
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for CNC in the last 3 months.
Highest
Current $68.86
$80.00 (+16.18%)
Average
$72.92 (+5.90%)
Lowest
$65.00 (-5.61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ben Hendrix
RBC Capital
Hold
Maintained
$71.00
+3.1%
10/07/2026
Lance Wilkes
Bernstein
Buy
Maintained
$79.00
+14.7%
10/05/2026
Kevin Fischbeck
Bank of America Securities
Buy
Reiterated
$80.00
+16.2%
09/24/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$80.00
+16.2%
09/17/2026
Stephen Baxter
Wells Fargo
Hold
Maintained
$69.00
+0.2%
09/15/2026
John Stansel
J.P. Morgan
Hold
Reiterated
$67.00
-2.7%
08/20/2026
John Staszak
Argus Research
Buy
Upgraded
$80.00
+16.2%
08/10/2026
Sarah James
Cantor Fitzgerald
Buy
Reiterated
$75.00
+8.9%
07/28/2026
Erin Wright
Morgan Stanley
Hold
Maintained
$66.00
-4.2%
07/29/2026
Jason Cassorla
Guggenheim
Hold
Maintained
-
-
07/28/2026
David S Macdonald
Truist Financial
Buy
Reiterated
$80.00
+16.2%
07/29/2026
A.J. Rice
UBS
Hold
Maintained
$70.00
+1.7%
07/29/2026
Michael Ha
Robert W. Baird
Hold
Maintained
$66.00
-4.2%
07/29/2026
Ryan Langston
TD Cowen
Hold
Reiterated
$65.00
-5.6%
07/30/2026
Joanna Gajuk
Bank of America Securities
Buy
Maintained
$74.00
+7.5%
07/17/2026
Ann Hynes
Mizuho Securities
Hold
Maintained
$69.00
+0.2%
07/13/2026
George Hill
Deutsche Bank
Buy
Upgraded
$80.00
+16.2%
05/20/2026
Scott Fidel
Goldman Sachs
Sell
Maintained
$40.00
-41.9%
04/29/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
$58.00
-15.8%
04/29/2026
David Windley
Jefferies
Hold
Maintained
$39.00
-43.4%
04/20/2026
Next call in 14 days
Tue, Oct 27, 2:30 PM
Fiscal period
Q3 2026
- / $0.10
Revenue / Est. (USD)
- / 46.98B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
45.35B
45.09B
45.06B
44.81B
Cost of goods sold
40.90B
41.49B
38.30B
39.03B
Cost of revenue
40.90B
41.49B
38.30B
39.03B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.14B
3.35B
3.38B
3.05B
Operating expense
4.20B
4.45B
4.48B
4.10B
Total operating expenses
45.10B
45.94B
42.78B
43.12B
Operating income
248.00M
-847.00M
2.28B
1.68B
Other non operating income
-
-
-
-
EBT including unusual items
-6.67B
-1.54B
2.10B
1.49B
EBT excluding unusual items
78.00M
-1.02B
2.12B
1.53B
Income tax expense
-42.00M
-443.00M
560.00M
399.00M
Effective tax rate
0.63%
28.71%
26.68%
26.85%
Other operating expenses
745.00M
771.00M
794.00M
745.00M
Net income
-6.63B
-1.10B
1.54B
1.09B
Net profit margin
-14.62%
-2.44%
3.42%
2.43%
Earnings per share
0.50
-1.19
3.37
2.51
Interest and investment income
-
-
-
-
Interest expense
-170.00M
-168.00M
-164.00M
-153.00M
Net interest expenses
-170.00M
-168.00M
-164.00M
-153.00M
Depreciation and amortization charges
147.00M
160.00M
134.00M
139.00M
EBITDA
565.00M
-518.00M
2.58B
1.98B
Gain or loss from assets sale
-
501.00M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps